deflazacort 18 MG Oral Tablet
deflazacort
RxCUI: 1870954
What the CMS Formulary Data Shows for deflazacort 18 MG Oral Tablet
Per the CMS 2026 Part D formulary file, deflazacort 18 MG Oral Tablet (RxNorm concept RXCUI 1870954, generic name deflazacort) appears on 26 distinct formulary files spanning 833 Medicare Part D plan offerings - 16.4% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.5.
Real-world access to deflazacort 18 MG Oral Tablet depends on utilization management as much as tier placement: 96.2% of covering formularies require prior authorization. 0% require step therapy. 30.8% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 99 Part D beneficiaries filled deflazacort 18 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $15,369,330 and an average per-beneficiary annual cost of $155,245.76. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry deflazacort 18 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 26
- Plans covering
- 833
- Coverage rate
- 16.4%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 5, Specialty
Restrictions
- Prior authorization required
- 96.2% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 30.8% of formularies
2023 Medicare Spending
- Beneficiaries
- 99
- Total spending
- $15,369,330
- Avg per beneficiary
- $155,245.76
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering deflazacort 18 MG Oral Tablet
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is deflazacort 18 MG Oral Tablet covered by Medicare Part D?
Yes, deflazacort 18 MG Oral Tablet is covered by 833 Medicare Part D plans (16.4% of all Part D formularies).
What tier is deflazacort 18 MG Oral Tablet on Medicare Part D plans?
deflazacort 18 MG Oral Tablet averages Tier 4.5 across Part D plans, ranging from Tier 1 to Tier 5.
Does deflazacort 18 MG Oral Tablet require prior authorization?
96.2% of Part D formularies require prior authorization for deflazacort 18 MG Oral Tablet. Step therapy: 0%. Quantity limits: 30.8%.
How much does Medicare spend on deflazacort 18 MG Oral Tablet?
In 2023, total Medicare Part D spending on deflazacort 18 MG Oral Tablet was $15,369,330, covering 99 beneficiaries. The average spend per beneficiary was $155,245.76.
Read our methodology - how this data is sourced, computed, and verified.